Health
·
The Punch
·
S’Africa lab to produce generic version of new twice-yearly HIV drug
A laboratory in South Africa has announced plans to manufacture a generic version of a new twice-yearly HIV drug. This development is expected to improve treatment accessibility and adherence by providing a long-acting alternative to daily medication for patients managing the condition across the continent.
Original story
Continue reading on The Punch.
facts.ng aggregates publicly available headlines and provides AI-generated summaries. The original article is published by The Punch; please visit them for the full report.